Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Vita Coco Company, Inc. (NASDAQ: COCO) said Chief Executive Officer Martin Roper sold 29,456 shares of common stock between April 10 and April 13, 2026, for about $1.48 million under a Rule 10b5-1 plan. Roper also exercised options to acquire the same number of shares at $10.178 per share, for a total exercise cost of $299,803. The company's shares…
Roku CEO Anthony J. Wood, via the Wood 2017 Revocable Trust, sold 48,250 shares of Class A common stock on April 10, 2026, for roughly $5,043,844 under a 10b5-1 plan. The company is changing its reporting by splitting the current Platform segment into Advertising and Subscriptions for the quarter ending March 31, 2026. Analysts have adjusted price …
Samsara Inc. Chief Accounting Officer Benjamin Louis Kirchhoff sold 2,480 shares of Class A common stock on April 13, 2026, for $26.02 per share, generating $64,529 in proceeds. The sale was made under a Rule 10b5-1 trading plan adopted September 30, 2025. Samsara recently posted fourth-quarter results that beat guidance and consensus, has ongoing …
Dolphin Entertainment Chief Executive William O’Dowd IV purchased 3,200 shares on April 13, 2026, paying $1.54 per share for a total of $4,928. The transaction was executed in several trades at prices between $1.53 and $1.55, and follows the company’s fourth-quarter and full-year 2025 results showing 10% revenue growth and a materially reduced net …
PubMatic Inc. CEO Rajeev K. Goel sold 44,000 shares of Class A common stock on April 13, 2026, for roughly $380,503 under a pre-arranged Rule 10b5-1 trading plan. The sale followed a transfer of shares through The Goel Family Trust and coincided with Goel exercising options to acquire and convert 17,466 Class B shares into Class A shares. The compa…
Brian Lieser, Executive Vice President and Chief Communications Officer of Belden Inc (NYSE: BDC), sold 2,719 shares on April 14, 2026, for $130.69 per share, generating proceeds of $355,346. The sale was made under a Rule 10b5-1 plan adopted August 11, 2025. After the transaction Lieser directly holds 32,959 shares and indirectly owns 635.9635 sha…
Doximity's interim finance chief, Sitaram Siddharth, sold 2,427 Class A shares on April 10, 2026, for $21.09 apiece, generating proceeds of $51,185, and on the same day exercised options to acquire 5,000 shares at $0. The transaction coincides with DOCS shares trading near a 52-week low and follows a series of analyst updates that range from downgr…
Heartflow Chief Executive Officer John C.M. Farquhar sold 22,562 shares on April 10, 2026, in a trade that generated $602,856. The transaction was carried out under a Rule 10b5-1 plan adopted in September 2025. Since the sale the shares have traded higher, and the company has reported an outperformance in its most recent quarter while initiating a …
Piyush B Sevalia, SiTime Corp's Executive Vice President and Chief Business Officer, sold 1,247 shares on April 10, 2026, for $425.00 each, generating $529,975. The transaction occurs while SiTime shares trade close to a 52-week high and following robust fourth-quarter 2025 earnings and a large office lease agreement for a new Santa Clara headquart…
Gina F. Adams, FedEx's Executive Vice President, General Counsel, and Secretary, sold 20,450 shares of common stock on April 14, 2026, for $7.49 million and on the same day exercised options to acquire 20,450 additional shares for $3.07 million. The transactions occurred as FedEx prepares to spin off its Freight division and follows several analyst…
Preet Kawal, an Executive Vice President at FedEx Corp (FDX), sold 4,900 shares on April 14, 2026, for $1,802,661 at $367.89 per share after exercising options that added 4,900 shares at two distinct exercise prices. Following the transactions Kawal holds 10,953 shares. The trades come amid strong recent stock performance and a planned FedEx Freigh…
Liquidia Corp CEO Roger Jeffs sold 54,177 shares in two transactions on April 10 and April 13, 2026, generating roughly $2.1 million. The sales, carried out under pre-arranged Rule 10b5-1 plans, coincided with the firm reporting strong Yutrepia revenue but an earnings-per-share shortfall that produced mixed investor responses.
Liquidia Corp Chief Business Officer Jason Adair executed a sale of 7,301 shares on April 13, 2026, netting $280,139 under a Rule 10b5-1 trading plan. The transaction comes amid a sizable one-year share-price rally and recent operational updates, including strong revenue from the Yutrepia launch and mixed fourth-quarter 2025 earnings.
Liquidia Corp's Chief Commercial Officer, Scott Moomaw, sold 10,547 shares on April 13, 2026, under a Rule 10b5-1 plan, netting about $404,401. The transaction comes as the stock trades near $38.71 after a 181% gain over the past year. Separately, Liquidia reported robust fourth-quarter 2025 revenue driven by Yutrepia sales, provided revenue guidan…
Liquidia Corp Chief Human Resource Officer Sarah Krepp sold 4,557 shares of common stock on April 13, 2026, at $38.37 per share, netting $174,852. The sale was carried out under a Rule 10b5-1 plan to satisfy tax withholding tied to settlements of restricted and performance stock units. Earlier in the week Krepp exercised options for 3,179 shares th…
Liquidia Corp's Chief Accounting Officer Dana Boyle sold 5,101 shares on April 13, 2026, under a pre-set Rule 10b5-1 plan, generating roughly $195,725. Boyle also exercised 3,179 PSUs on April 10. Following these moves, Boyle holds 176,918 shares including unvested RSUs and employee purchase plan shares. The company reported stronger-than-expected …
Liquidia Corp's (NASDAQ: LQDA) Chief Financial Officer and Chief Operating Officer, Michael Kaseta, completed two stock sales on April 10 and April 13, 2026, disposing of 42,779 shares for roughly $1.68 million at prices between $38.37 and $40.1431. The transactions occurred under Rule 10b5-1 trading plans. On the same date he also exercised incent…
SoftVest, LP, a holder of roughly ten percent of Cross Timbers Royalty Trust, purchased 6,844 units on April 10, 2026, spending $71,314 at a weighted average price of $10.42. The buy was reported in a Form 4 filing with the Securities and Exchange Commission. The transaction comes as CRT shares have climbed about 48% over the past six months and tr…
Ginkgo Bioworks CFO Steven P. Coen sold 33,171 Class A shares on April 13 to meet tax obligations from vested performance-based restricted stock units (PSUs), generating $212,758. The company has reported improvements in cash management and operational restructuring in its Q4 2025 results, while launching the Ginkgo Cloud Lab and expanding automati…
Applied Optoelectronics Chief Financial Officer Stefan J. Murry sold 4,000 shares on April 10, 2026, netting roughly $546,014 under a pre-established Rule 10b5-1 plan. The trade occurred as the company's stock traded close to its 52-week high and after the firm announced multiple large orders for 800G transceivers supporting data-center and AI infr…
AE Red Holdings, a roughly 10% holder and director in Redwire Corp (NASDAQ: RDW), sold 1,371,411 shares across two transactions in April 2026, realizing $13.1 million. The trades, executed on April 10 and April 13, reduced AE Red's stake while Redwire continues to secure government and space-industry contracts. The stock is trading at $9.79 and is …
A Veeva Systems director executed a planned sale of Class A shares on April 10, 2026, while the company advanced its AI-driven strategy through a roughly $100 million acquisition. The transaction occurred as the stock traded near its 52-week low and follows a range of analyst ratings and a lowered price target from Needham.
Exzeo Group Chief Executive Officer Paresh Patel bought 2,000 shares of the company’s common stock on April 13, 2026, at $15.13 per share, a transaction valued at $30,260. The stock has since traded up to $16.18. Patel now directly holds 1,610,013 shares and also controls options on 5,000,000 shares granted in 2021. The company recently reported fo…
Donaldson director Owens James disposed of 14,790 shares in mid-April 2026 for $1.76 million and simultaneously completed option exercises that resulted in the acquisition of 19,790 shares valued at $880,968. The moves were disclosed in a Form 4 filing and come after the company reported fiscal Q2 2026 results that fell short of analyst expectation…
Martine Rothblatt, Chairperson and CEO of United Therapeutics Corp (UTHR), completed a series of transactions on April 13, 2026 that included the sale of 9,495 shares for approximately $5.5 million and the exercise of 9,500 stock options. The trades were carried out under a 10b5-1 plan adopted on November 7, 2025. The company has also recently seen…
